Andrew Toy - 01 Jan 2023 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: Chief Executive Officer, Director
Signature: s/ Jessica Kirkland, as Attorney-in Fact
Issuer symbol: CLOV
Transactions as of: 01 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Jan 2023, 16:01:28 UTC
Previous filing: 10 Aug 2022
Next filing: 09 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Award	$0	+9,734,513	+361%	$0.000000	12,429,585	01 Jan 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of January 1, 2023, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of January 1, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date.

Content

Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of January 1, 2023, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of January 1, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date.

Remarks:

EXHIBIT LIST: EX-24 Power Of Attorney